118 related articles for article (PubMed ID: 16238095)
21. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of p21Waf1/Cip1 and JNK with costimulation of prostate cancer cell activation by an siRNA Egr-1 inhibitor.
Parra E; Gutiérrez L; Ferreira J
Oncol Rep; 2013 Aug; 30(2):911-6. PubMed ID: 23715767
[TBL] [Abstract][Full Text] [Related]
23. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes.
Zeigler ME; Chi Y; Schmidt T; Varani J
J Cell Physiol; 1999 Aug; 180(2):271-84. PubMed ID: 10395297
[TBL] [Abstract][Full Text] [Related]
24. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
[TBL] [Abstract][Full Text] [Related]
25. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
26. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
27. Essential role of mitogen-activated protein kinase pathway and c-Jun induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase.
Chen BK; Kung HC; Tsai TY; Chang WC
Mol Pharmacol; 2000 Jan; 57(1):153-61. PubMed ID: 10617690
[TBL] [Abstract][Full Text] [Related]
28. PP2A regulates upstream members of the c-jun N-terminal kinase mitogen-activated protein kinase signaling pathway.
Zhao B; Sun L; Haas M; Denenberg AG; Wong HR; Shanley TP
Shock; 2008 Feb; 29(2):181-8. PubMed ID: 17693927
[TBL] [Abstract][Full Text] [Related]
29. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
[TBL] [Abstract][Full Text] [Related]
30. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.
Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D
Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214
[TBL] [Abstract][Full Text] [Related]
31. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.
Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM
Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors.
Ma W; Gee K; Lim W; Chambers K; Angel JB; Kozlowski M; Kumar A
J Immunol; 2004 Jan; 172(1):318-30. PubMed ID: 14688340
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
[TBL] [Abstract][Full Text] [Related]
34. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
35. Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB.
Lee ZH; Kwack K; Kim KK; Lee SH; Kim HH
Mol Pharmacol; 2000 Dec; 58(6):1536-45. PubMed ID: 11093794
[TBL] [Abstract][Full Text] [Related]
36. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
Franklin CC; Kraft AS
Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
[TBL] [Abstract][Full Text] [Related]
37. Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal kinase and p38.
Ohsawa M; Koyama T; Nara N; Hirosawa S
Thromb Res; 2003; 112(5-6):313-20. PubMed ID: 15041276
[TBL] [Abstract][Full Text] [Related]
38. Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase.
Cadalbert L; Sloss CM; Cameron P; Plevin R
Cell Signal; 2005 Oct; 17(10):1254-64. PubMed ID: 16038800
[TBL] [Abstract][Full Text] [Related]
39. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK).
Todd JL; Rigas JD; Rafty LA; Denu JM
Oncogene; 2002 Apr; 21(16):2573-83. PubMed ID: 11971192
[TBL] [Abstract][Full Text] [Related]
40. JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA).
Ikezoe T; Yang Y; Taguchi H; Koeffler HP
Br J Cancer; 2004 May; 90(10):2017-24. PubMed ID: 15138488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]